Cem Meriç, MBA - Clinical Sales Specialist - Terumo Europe | LinkedIn
PRODUCT CATALOGUE
Terumo BCT and Marker Therapeutics received the first device FDA Emergency Use Authorization (EUA) to treat acute respiratory failure in COVID-19 patients
TERUMO – Özgün Kimya
Terumo Blood and Cell Technologies - Terumo BCT
Mehmet Ozdemir - Finance and Administration Manager - Terumo Blood and Cell Technologies | LinkedIn
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro | Protocol (Translated to Turkish)